KimerDx wins Venture Challenge
Fall 2013

Advanced technologies for post-transplant monitoring improves patient care

December 2, 2013
Molecular diagnostics start-up KimerDx is the winner of the Venture Challenge Fall 2013, which includes €25,000 prize money. KimerDx develops advanced technologies that allow early detection of rejection or disease relapse in transplant patients. Six teams participated in this edition of the Venture Challenge, an intensive track for life sciences start-ups.

Together the teams covered a broad range of life sciences topics, ranging from animal-free methods for toxicity testing to novel polymers for minimally invasive knee surgery and from medical food products for patients with weakened immune systems to new analysis methods for complex biological data.

According to the jury, consisting of established life sciences experts, the team behind KimerDx is experienced, diverse and highly motivated. One of the members is a seasoned entrepreneur who knows the industry very well and the team has already managed to secure external funding. Moreover, KimerDx is tackling a clear market need as key opinion leaders in the fields of both stem cell and organ transplantation have stated. New methods to improve post-transplant monitoring are urgently needed and KimerDx is proposing a feasible solution.

About KimerDx
In transplant medicine, early detection of transplant rejection or disease relapse is critical for the adjustment of the patient's treatment regime, graft survival and overall quality of life. KimerDx focuses on developing and commercialising advanced technologies that can change the way transplant medicine is practised today. Clinical testing has demonstrated that adverse events may be detected 3-4 months earlier using the approaches offered by KimerDx compared to the current Golden Standard monitoring methods. KimerDx's solutions will enable new applications, which will result in improved patient care and survival rates.


For more information:
Chrétien Herben, Manager NGI Valorisation | Netherlands Genomics Initiative
T +31 70 344 0959 |

About the Venture Challenge
The Venture Challenge offers advice and coaching on essential elements of setting up a life sciences business. In two 3-day workshops, participating teams are continuously challenged by the facilitators and each other to streamline their business plan and improve their 'pitch'. The team with the best business plan and pitch is awarded €25,000 to further develop their venture.

The Venture Challenge is part of the start-up support programme: LifeSciences@work -



About this mailing
You received this mailing because you have signed up for NGI updates or have participated in
one of the NGI Valorisation activities for start-ups. If you wish not to receive NGI Valorisation updates, please unsubscribe here.